DEK promotes mammary hyperplasia and is associated with H3K27me3 epigenetic modifications
Life Science Alliance · 2025
DOI: 10.26508/lsa.202503230 ↗Kurz gefasst
Fachartikel in der Zeitschrift Life Science Alliance, 2025. Verfasst von Megan E Johnstone und 10 weiteren Autor:innen. Beteiligte Einrichtung: Division of Oncology, Cancer and Blood Diseases Institute, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA. Hauptthemen laut MEDLINE: Histones, Mammary Glands, Animal, Epigenesis, Genetic, Chromosomal Proteins, Non-Histone. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 67 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, University of Cincinnati Cancer Center, Cincinnati Children’s Hospital Trustee Award.
Abstract (Originalsprache)
The DEK chromatin remodeling protein has oncogenic functions in breast cancers, but its functional role in normal mammary gland epithelium has remained unexplored. We developed two novel genetically engineered mouse models to study the role of Dek in normal mammary gland biology in vivo. Mammary gland-specific Dek transgenic mice developed hyperplasia and had a transcriptional profile that revealed increased expression of cell cycle, mammary stem/progenitor, and lactation-associated genes. Conversely, Dek knockout mice exhibited mammary gland functional defects resulting in dramatically reduced pup survival. Analysis of previously published scRNA-sequencing of mouse mammary glands revealed that Dek is most highly expressed in mammary stem cells and alveolar progenitor cells, supporting the observed phenotypes. Mechanistically, we discovered that Dek is a modifier of Ezh2 methyltransferase activity, up-regulating the levels of histone H3K27me3 to control gene transcription. Combined, this is the first report to show that Dek promotes proliferation of mammary epithelial cells via transcriptional deregulation of cell cycle genes, potentially via epigenetic mechanisms, in vivo.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Division of Oncology, Cancer and Blood Diseases Institute, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA.
- Department of Cancer Biology, University of Cincinnati College of Medicine, Cincinnati, OH, USA.
- Information Services for Research, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA.
- Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, OH, USA.
- Division of Natural and Applied Sciences, Duke Kunshan University, Kunshan, Jiangsu, China.
- Division of Biomedical Informatics, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA.
ORCID-Profile: Ferdinand Kappes
Förderung
- NCI NIH HHS
- University of Cincinnati Cancer Center
- Cincinnati Children’s Hospital Trustee Award
- HHS | National Institutes of Health
- Duke Kunshan University Wang Chai and Start up grant
Zitieren
APA
Johnstone, M. E., Leck, A. L., Lange, T. E., Wilcher, K. E., Shephard, M. S., Paranjpe, A., Schutte, S., Wells, S. I., Kappes, F., Salomonis, N., & Privette Vinnedge, L. M. (2025). DEK promotes mammary hyperplasia and is associated with H3K27me3 epigenetic modifications. Life Science Alliance. https://doi.org/10.26508/lsa.202503230
Vancouver
Johnstone ME, Leck AL, Lange TE, Wilcher KE, Shephard MS, Paranjpe A, et al. DEK promotes mammary hyperplasia and is associated with H3K27me3 epigenetic modifications. Life Science Alliance. 2025. doi:10.26508/lsa.202503230
BibTeX
@article{Johnstone2025,
author = {Johnstone, Megan E and Leck, Ashley L and Lange, Taylor E and Wilcher, Katherine E and Shephard, Miranda S and Paranjpe, Aditi and Schutte, Sophia and Wells, Susanne I and Kappes, Ferdinand and Salomonis, Nathan and Privette Vinnedge, Lisa M},
title = {DEK promotes mammary hyperplasia and is associated with H3K27me3 epigenetic modifications},
journal = {Life Science Alliance},
year = {2025},
doi = {10.26508/lsa.202503230}
}
EUVIMED